Participants, who ranged in age from 19 to 74 and had an average BMI of 36, were assessed for binge-eating disorder at the beginning of the study and re-examined 2.5 and 5 years later. After five ...

Armanious said the study's findings underscore the need for a more nuanced understanding of lisdexamfetamine's effects on patients with binge eating disorder. The development of new medications ...

Trytamine receives approval from Swinburne University Human Research Ethics Committee for trial of proprietary psilocin-based ...

In one study, 255 people got different doses of ... Vyvanse isn't approved to treat binge eating in children. If you've ever been dependent on or abused prescription drugs, street drugs, or ...

Rutgers Health researchers have uncovered mixed outcomes for patients using lisdexamfetamine, a stimulant commonly prescribed for binge eating disorder (BED). The study, led by Abanoub Armanious ...

It is now the only approved medication for moderate to severe binge eating disorder in adult patients. The study, published ...

Shi, a former psychological doctor at the Medical Psychology Department of the PLA General Hospital Third Medical Center, ...

The study found that semaglutide was more effective ... related drugs curb appetite” on this page to learn more.) Binge eating disorder is a mental health condition that involves periods of ...

One recent study, based on an analysis of adverse ... said she worries that GLP-1 drugs could make the symptoms of binge eating disorder worse. Many people combine binge eating with restricted ...

The study authors reported no relevant financial conflicts of interest. Hutner reported no conflicts of interest. Source Reference: Cooney LG, et al "Increased prevalence of binge eating disorder ...

Armanious said the study’s findings underscore the need for a more nuanced understanding of lisdexamfetamine’s effects on patients with binge eating disorder. The development of new ...